Mouse and lab research suggests a protein called Orm1 helps protect fatty livers from injury when blood flow is cut off and restored, as happens in transplants. In mice on a high-fat diet, blocking Orm1 more than doubled liver damage markers, and in lab cells it raised survival by 35%. Gram Research analysis suggests it could help make fatty donor livers safer to use.

Fatty livers from donors are often turned down for transplant because they are easily damaged when blood flow is cut off and then restored. A research team studied a natural protein called Orm1 to see whether it could protect these livers. In mice fed a high-fat diet, lowering Orm1 made liver injury much worse, with liver enzyme levels more than doubling and more liver cells dying. In lab-grown liver cells loaded with fat, adding extra Orm1 helped cells survive oxygen stress and improved cell survival by 35%. The researchers found that Orm1 appears to protect a second protein, Prdx1, from being broken down, which keeps a cell survival pathway active. Gram Research analysis suggests this pathway could become a target for making fatty donor livers safer to use. These results come from animal and cell studies, so human testing is still needed.

Key Statistics

A 2026 study published in the International Journal of Molecular Medicine found that mice fed a high-fat diet had more than double the liver damage markers after blood flow was restored when their Orm1 protein levels were lowered.

In a 2026 laboratory study of fat-loaded liver cells, adding extra Orm1 protein improved cell survival by 35% after low oxygen followed by reoxygenation.

The 2026 gene activity analysis in fatty mouse livers identified 1,551 genes that changed after blood flow was interrupted and restored, with Orm1 among the most strongly increased.

The Quick Take

  • What they studied: Can a natural protein called Orm1 protect fatty livers from the damage that happens when blood flow is stopped and then restored, such as during transplant surgery?
  • Who participated: The study used laboratory mice fed a high-fat diet to make their livers fatty, along with liver cells grown in a lab dish. The exact number of mice was not specified in the summary provided.
  • Key finding: When researchers reduced the amount of Orm1 in fatty mouse livers, injury after blood flow was restored got much worse, with liver enzyme levels more than doubling. When they added extra Orm1 to fat-loaded lab cells, cell survival improved by 35%.
  • What it means for you: This is early research in animals and cells, so it does not mean you should change your diet or supplements. It may eventually help doctors find ways to make fatty donor livers safer for transplant, but that is not yet proven in people.

The Research Details

The researchers first looked at gene activity in fatty livers after blood flow was cut off and then restored. They found 1,551 genes that changed their activity, and one of the most strongly increased was Orm1. This step helped them choose Orm1 as a protein worth studying further.

Next, they tested what Orm1 does. In mice on a high-fat diet, they used a harmless virus to lower Orm1 levels in the liver, then caused the blood flow interruption and restoration. They also added extra Orm1 to liver cells that had been loaded with two common fats and then exposed to low oxygen followed by normal oxygen.

To find out how Orm1 works, the team studied which genes switched on or off when Orm1 was lowered, and they tested which proteins Orm1 physically binds to. They found that Orm1 links to Prdx1 and helps keep it from being broken down. They then blocked Prdx1 or a key signaling molecule called Akt to see whether the protective effect disappeared.

Using both whole animals and lab cells lets researchers see the effect in a living body and also explain the cell-level mechanism. Changing the protein up and down in both settings helps show that Orm1 is actually responsible for the protection, rather than just being associated with it. Blocking the pathway and seeing the benefit disappear adds further support for how the protein works.

The study combines several methods, including gene activity profiling, protein binding tests, animal experiments, and lab cell experiments, which supports the findings. However, the summary does not state how many mice or cell experiments were used, which makes it harder to judge how reliable the numbers are. Animal and cell findings also do not always translate to people, so results should be seen as early evidence. The paper is listed with a 2026 publication date, and its full methods and statistics would be needed for a complete quality review.

What the Results Show

The first major finding was that Orm1 rises sharply in fatty livers after blood flow is interrupted and restored. Among 1,551 genes that changed activity, Orm1 was one of the clearest examples of increased expression. This suggests the liver may naturally try to defend itself by turning on this protein when it is under stress.

The second finding was that Orm1 appears to protect the liver when it is needed. Mice fed a high-fat diet that had Orm1 reduced showed serum ALT and AST levels, which are markers of liver damage, that more than doubled after the injury. These mice also had more dead liver cells from both necrosis and programmed cell death, known as apoptosis.

The third finding came from lab-grown liver cells loaded with fat. Adding extra Orm1 reduced harmful reactive oxygen species, which are unstable molecules that damage cells, and improved cell survival by 35% after low oxygen and recovery. This supports the idea that Orm1 protects cells directly, not just through the surrounding tissue.

The fourth finding explained part of the mechanism. Orm1 binds to Prdx1 and helps stop Prdx1 from being broken down by the cell’s protein disposal system. When Prdx1 was blocked or Akt was inhibited, the protective effect of Orm1 was reversed, which suggests the Orm1, Prdx1, and PI3K/Akt pathway works as a chain.

Lowering Orm1 in mice changed the activity of 3,327 genes, and these changes were strongly concentrated in the PI3K/Akt pathway. This pathway is a well-known cell survival system that helps cells resist stress and avoid self-destruction. The fact that many genes in this pathway changed together supports the idea that Orm1 acts as a central switch for this survival signal.

The study also points to Prdx1 as an important partner in this process. Prdx1 is an antioxidant-related protein that helps cells manage harmful oxidative stress. Because its loss weakened the protective effect, Prdx1 may be a useful target for future research, though this has not been tested in people.

Fatty livers are known to be more fragile than healthy livers during blood flow interruption, which is why many are discarded for transplant. Earlier research has shown that the body’s stress response and cell survival signals, including the PI3K/Akt pathway, play important roles in protecting organs from this kind of injury. This study builds on that knowledge by identifying a specific protein, Orm1, that appears to feed into this pathway. It adds a new piece to the puzzle rather than overturning previous ideas.

The most important limitation is that this research was done in mice and in lab-grown cells, not in people. Mouse livers and human livers can respond differently to injury, fat buildup, and treatment. The summary also does not state how many mice or experiments were used, which makes the strength of the numbers harder to judge.

The study focused on a short-term injury model, so it does not show whether Orm1 protects livers over longer periods or in real transplant patients. It also does not test whether adding Orm1 as a treatment is safe or practical. Future studies would need to test these questions before any clinical use is possible.

The Bottom Line

Based on this early research, the finding that Orm1 helps protect fatty livers from blood flow injury is promising but preliminary. Confidence is moderate for the mechanism in mice and lab cells, and low for any direct benefit in humans. No changes to diet, supplements, or medical care should be made based on this study alone.

Transplant surgeons, liver researchers, and people working on organ preservation may find this study especially relevant. Patients with fatty liver disease or people awaiting a liver transplant may find it interesting, but should talk with their own doctor before drawing any conclusions. General readers do not need to act on these findings at this stage.

Turning lab findings like these into treatments usually takes many years. Animal studies typically come first, followed by safety testing and clinical trials in people. Any future use of Orm1-based approaches in transplant care would likely be a long way off, and it is not possible to predict a timeline with confidence.

Frequently Asked Questions

What is Orm1 and how does it affect fatty livers?

Orm1 is a natural protein that appears to protect fatty livers from injury. In a 2026 mouse study, it helped keep a cell survival pathway active and reduced liver damage after blood flow was restored. Researchers say more human research is needed.

Can fatty donor livers be made safer for transplant?

Fatty donor livers are often discarded because they are fragile during transplant. Early research on the Orm1 protein suggests it may someday help protect them, but this has only been tested in mice and lab cells so far, not in human patients.

Should I take a supplement to boost Orm1 for my liver?

No supplement has been shown to raise Orm1 or protect human livers. This 2026 research was done in mice and lab cells. To support liver health now, focus on limiting alcohol, staying physically active, and talking with your doctor about any liver concerns.

How does Orm1 protect liver cells from damage?

In mouse and lab studies, Orm1 binds to a protein called Prdx1 and helps keep it from being broken down. This keeps the PI3K/Akt cell survival pathway active, which was linked to 3,327 changed genes in the mouse livers.

Want to Apply This Research?

  • Track your general liver health habits in the app, such as weekly alcohol intake in drinks, number of days per week with at least 30 minutes of activity, and daily servings of vegetables. These are measurable, evidence-based steps that support liver health, though they are not a test of Orm1 levels.
  • Encourage users to focus on steps proven to support liver health, such as limiting alcohol, staying active, and eating more whole foods and fewer refined sugars. Remind users that this study does not recommend any supplement or food to raise Orm1 levels.
  • Over the long term, users with known fatty liver disease can log their doctor-recommended lab results, such as ALT and AST, if their doctor agrees. Trends over several months are more useful than single readings, and any changes should be reviewed with a healthcare provider.

This article summarizes a laboratory study conducted in mice and cultured liver cells, not in people. The findings are early and preliminary and should not be used to make decisions about diet, supplements, or medical treatment. Anyone with fatty liver disease or considering a liver transplant should talk with a qualified healthcare provider.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Orm1 protects steatotic livers against ischaemia‑reperfusion injury by stabilising Prdx1 and activating the Pi3k/Akt axis. , International journal of molecular medicine (2026). PubMed 42992554 | DOI
Topics
Orm1 protein fatty liver liver transplant ischemia reperfusion injury Prdx1 PI3K/Akt pathway steatotic liver liver cell survival